Patent · US Expired

Macrolides

US7202221B2 · kind B2 · utility

0Cited by

2References

9Claims

0Family size

Assignees

Glaxo Group Limited · GB
Pliva D.D. · HR

Inventors

Suleman Alihodzic · Zagreb, HR
Daniele Andreotti · Verona, IT
Andrea Berdik · Zagreb, HR
Ilaria Bientinesi · Verona, IT
Stefano Biondi · Verona, IT
Manuela Ciraco · Verona, IT
Federica Damiani · Verona, IT
Marko Djerek · Zagreb, HR
Miljenko Dumic · Zagreb, HR
Vesna Erakovic · Zagreb, HR
Antun Hutinec · Zagreb, HR
Gorjana Lazarevski · Zagreb, HR
Sergio Lociuro · Lugano, CH
Natasa Marsic · Zagreb, HR
Zorica Marusic-Istuk · Samobor, HR
Stjepan Mutak · Zagreb, HR
Alfredo Paio · Cernusco sul Naviglio, IT
Drazen Pavlovic · Zagreb, HR
Anna Quaglia · Verona, IT
Wolfgang Schoenfeld · Zagreb, HR
Vlado Stimac · Zagreb, HR
Jessica Tibasco · Verona, IT

Key dates

Filing date	Nov 13, 2002
Grant date	Apr 10, 2007
Priority date	—
Expiry date	Jun 6, 2023

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to 14 or 15 membered macrolides substituted at the 4′ position of formula (I) and pharmaceutically acceptable salts and solvates thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical bacterial infections in a human or animal body

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.